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Abstract
Introduction
Recent efforts to increase CRT response by multiSPOT pacing (MSP) from multiple bipols
on the same left ventricular lead are still inconclusive.
Aim
The Left Ventricular (LV) MultiSPOTpacing for CRT (iSPOT) study compared the acute
hemodynamic response of MSP pacing by using 3 electrodes on a quadripolar lead com-
pared with conventional biventricular pacing (BiV).
Methods
Patients with left bundle branch block (LBBB) underwent an acute hemodynamic study to
determine the %change in LV+dP/dtmax from baseline atrial pacing compared to the follow-
ing configurations: BiV pacing with the LV lead in a one of lateral veins, while pacing from
the distal, mid, or proximal electrode and all 3 electrodes together (i.e. MSP). All
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measurements were repeated 4 times at 5 different atrioventricular delays. We also mea-
sured QRS-width and individual Q-LV durations.
Results
Protocol was completed in 24 patients, all with LBBB (QRS width 171±20 ms) and 58%
ischemic aetiology. The percentage change in LV+dP/dtmax for MSP pacing was 31.0
±3.3% (Mean±SE), which was not significantly superior to any BiV pacing configuration:
28.9±3.2% (LV-distal), 28.3±2.7% (LV-mid), and 29.5±3.0% (LV-prox), respectively. Corre-
lation between LV+dP/dtmax and either QRS-width or Q-LV ratio was poor.
Conclusions
In patients with LBBBMultiSPOT LV pacing demonstrated comparable improvement in con-
tractility to best conventional BiV pacing. Optimization of atrioventricular delay is important
for the best performance for both BiV and MultiSPOT pacing configurations.
Trial Registration
ClinicalTrials.gov NTC01883141
Introduction
Cardiac Resynchronization Therapy (CRT) is an effective treatment for patients with systolic
heart failure and a wide QRS, however approximately 30% of patients fail to respond.[1] Sev-
eral mechanisms may explain this observation, including the presence of substrate not amena-
ble to CRT, the absence of dyssynchrony, or the inability to achieve optimal resynchronization
via the implanted system. Non-optimal left ventricular (LV) lead positioning has been pro-
posed as a non-response factor[2, 3] and therefore pacing from multiple LV sites via a second
LV lead[4, 5] or by multiple-electrodes pacing using a multipolar lead has been proposed to
increase the response.[6–8] The use of multiSPOT pacing (MSP) via a quadripolar lead to
improve CRT-response has been investigated with differing results. Some studies have failed to
show additional benefit[9, 10] while others have shown small acute benefits.[11–15] These lat-
ter studies are difficult to interpret because of differing methodology including non-optimal
atrio-ventricular (AV) delays.[11–15] Assessment of the true acute hemodynamic and clinical
benefit of MSP requires assessment in a robust and reliable fashion to allow conclusions can be
drawn with an acceptable degree of certainty before this treatment can be adopted into clinical
practice.
Aim
The iSPOT study intended to assess the positive LV +dP/dt max achieved by multiple (3) LV
pacing SPOTs, i.e. MultiSPOT configuration in comparison to the response achieved by the
current standard BiV pacing configuration. The protocol included a rigorous methodology to
decrease measurement variability and to be patient-tailored (through individualized AV-delay)
in order to provide a justified conclusion to the acute hemodynamic benefit of MSP [16]. In
addition, only left bundle branch (LBBB) patients were selected in order to adequately address
the potential benefit of MSP in this large CRT patient population. In addition to the
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PLOS ONE | DOI:10.1371/journal.pone.0154024 April 28, 2016 2 / 16
advisory panel in the development of the trial and
provided guidance for the manuscript preparation and
submission process. Medtronic will also assist with
any publication fees incurred. The funder had a role
in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: Dr. Sterlinski receives
consulting fees from Biotronik, Medtronic, St. Jude
Medical, and Zoll Medical Corporation. Dr. Sokal and
Dr. Lenarczyk receive consulting fees from Biotronik,
Medtronic and St. Jude Medical. Dr. Rinaldi receives
support from Medtronic. Dr Francis receives
consulting fee from CVRx. B. Stegemann, J. Heynens
and R. Cornelussen are employees of Medtronic Inc.
This does not alter the authors' adherence to PLOS
ONE policies on sharing data and materials.
hemodynamic evaluation, electrical parameters including Q-LV timing and QRS-width for all
the pacing configurations were measured and compared.
Material and Methods
Study design
The study was an international, prospective, interventional, non-randomized research study
conducted at 7 high-volume sites. Inclusion and exclusion criteria are listed in Table 1. In eligi-
ble patients, contractility was measured using LV+dP/dt max at various LV pacing sites. The
hemodynamic study was done immediately prior to a planned CRT-implant either concomi-
tant or later. All patients were enrolled prospectively, served as their own control and gave writ-
ten informed consent before the start of the study. The study was approved by government
authorities and the local ethical committees. All ethics committees approvals are listed in
Table 2.
Following a coronary venogram to identify the target vessels for LV stimulation a quadripo-
lar lead (PerformaTM,Medtronic plc,Minneapolis,MN or QuartetTM, St Jude Medical, Sylmar,
CA) or a decapolar catheter (TORQR,Medtronic plc,MSP,MN) was advanced to the target
vein by subclavian approach: the LV electrode positions were determined using a qualitative
approach; using the MRI images to determine the length of the LV axis (AV-plane of the coro-
nary sinus vein (designated base of the heart), to the apex) and the fluoroscopy images to quali-
tatively determine the distance of the electrodes from the base. CRT contractility was measured
using LV+dP/dt via aMicro-Cath™ catheter Millar,Texas, USA placed in the left ventricle via
the femoral artery.
Pacing system. Four individual cardiac stimulators (5388 DDD,Medtronic plc) synchro-
nized by aModel 2090 programmer were used for simultaneous, independent, multi-site pacing
of the left ventricle. To facilitate connections and improve safety during the EP procedure, a
custom-made connection box was used for simultaneous stimulation at various sites.
Table 1. Study inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Sinus rhythm Permanent atrial fibrillation/ flutter or tachycardia
Left bundle branch block Recent myocardial infarction, within 40 days prior to enrollment.
Left ventricular ejection fraction  35% Coronary artery bypass graft or valve surgery, within 90 days
prior to enrollment
Heart failure in II- ambulatory IV NYHA
class
Heart transplantation, or patient is actively listed on the
transplantation list
Written informed consent Left ventricular assist device
Optimal heart failure pharmacotherapy
for at least 3 months
Severe renal disease (up to physicians discretion)
Continuous or uninterrupted infusion (inotropic) therapy for heart
failure ( 2 stable infusions per week
Severe aortic stenosis (with a valve area of <1.0 cm2 or
significant valve disease expected to be operated within study
period)
Complex and uncorrected congenital heart disease
Mechanical heart valve
Pregnant or breastfeeding women, or women of child bearing
potential and who are not on a reliable form of birth control
Enrollment in at least one concurrent study
doi:10.1371/journal.pone.0154024.t001
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Recording equipment. Throughout the procedure all physiological signals (intra-cardiac
EGM, ECG, and left ventricular pressure) were acquired real time with a 32 channel physiolog-
ical recording system (Porti, TMSI, Twente, NL) and recorded using customized software. All
configurations and experimental settings were annotated digitally on the same system. Signals
were visualized on the laptop computer throughout the study to assess signal quality and to
confirm adequate therapy delivery. No data analysis was performed at this stage.
Study protocol
The following LV pacing configurations were evaluated:
1. Biventricular pacing with pacing RV and LV on the distal electrode (LV-dist)
2. Biventricular pacing with pacing RV and LV on the mid electrode (LV-mid)
3. Biventricular pacing with pacing RV and LV on the proximal electrode (LV-prox)
4. RV and simultaneous LV pacing on all three electrodes (MSP)
To avoid the effects exerted on LV performance by different heart rates, pacemakers were
programmed to pace in DDDmode at a lower rate of 100 bpm to ensure atrial and ventricular
capture. It was decided to have one fixed heart rate for all patients and 100 bpm was well toler-
ated. In addition, the higher heart rate was found to be more sensitive to changes in contractil-
ity when using the different CRT configurations. For all configurations the VV delay was set at
0 ms. For each configuration, measurements were performed at 5 different AV delays: the
patient specific optimal AV delay determined by using the CardioSyncTM algorithm, the opti-
mal AV delay +/-20 and +/-40 ms [17]. All measurements were repeated four times for each
pacing configuration and AV-delay to increase the signal to noise ratio. Each setting lasted 20
beats (10–15 s) interspersed with baseline AAI pacing.
Data Analysis
Data analysis was reviewed off-line and where needed the correct start and end of the AAI and
DDD pacing sequences were manually corrected. Premature complexes, and beats with loss of
capture were manually annotated. Thereafter, final analysis was done on annotated data files
using a validated custom-made program written inMatlab™.
The paced QRS duration was measured from the beginning of the ventricular pacing spike
to the end of the QRS complex in surface ECG. The Q-LV interval was defined as the interval
Table 2. Numbers of local and central ethics committees approvals for all participating sites.
Site Local ethics committee
approval number
Central ethics committee
approval (CA) number
CA Agency
Belgium—Aalst B670201215037 80M0524 Federal Agency for Medicines and
Health Products
Belgium—Ghent B670201215037 80M0524 Federal Agency for Medicines and
Health Products
Israel—Ashkelon 0092-12-BRZ HTA6661 Ministry of Health
Poland—Warsaw KNW/0022/KB/W/9/13 No CA needed No CA needed
Poland—Katowice KNW/0022/KB1/26/IV/13 No CA needed No CA needed
UK—London (Imperial College
Healthcare NHS Trust
12/LO/1762 CI/2013/0013 Medicines & Healthcare Products
Regulatory Agency
UK—London (St Thomas Hospital) 12/LO/1762 CI/2013/0013 Medicines & Healthcare Products
Regulatory Agency
doi:10.1371/journal.pone.0154024.t002
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from the onset of the intrinsic QRS on the surface ECG to the first large positive or negative
peak of the LV electrogram. Q-LV-timing data are expressed as Q-LV-ratio which is the ratio
of the Q-LV-time and QRS-width.
Statistical analysis. Statistical analysis was performed using SAS 9.4 (SAS Institute,Cary
NC) and R (versions up to 3.2.0). The primary objective was to compare the acute hemody-
namic response of a MultiSPOT LV pacing configuration to a BiV configuration using
%-change LV+dP/dtmax from baseline (AAI pacing). In the first step, the maximal average—
change LV+dP/dtmax response was calculated for each subject and each configuration by a
regression analysis constructing a quadratic curve through all AV-delays. From this step, a
%-change of LV+dP/dtmax value for each patient within each configuration was obtained. In
the second step, paired t-tests were performed to compare the configurations to each other. A
subgroup analysis was performed comparing MultiSPOT and BiV configurations within ische-
mic and non-ischemic patients. Superiority testing at a 0.05 significance level was performed
after significance of non-inferiority at a 0.025 level and 4% non-inferiority margin. Since non-
inferiority testing was significant in most comparisons, only p-values for superiority are pre-
sented (unless indicated otherwise). The hypotheses are explained below:
The null hypothesis for non-inferiority was as follows:
H0 : Dmultispot DBiV   4% ðinferiorityÞ;
where Δmultispot indicates the percentage change LV dP/dt max for the multispot pacing config-
uration and ΔBiV indicates the percentage change for a given BiV pacing configuration.
This null hypothesis was tested against the alternative hypothesis:
H1 : Dmultispot DBiV >  4% ðnon inferiorityÞ:
A p-value smaller than 0.025 was considered significant, and consequently the null hypothe-
sis was rejected. Testing at 0.025 level means that p-values smaller than 0.025 are considered
significant. The non-inferiority margin of 4% was chosen based on literature research. The
non-inferiority margin is here 4% and represents the acceptable difference between multispot
and BiV pacing above which we would declare multispot to be non-inferior.
After rejection of non-inferiority of multispot to BiV pacing, superiority of multispot pacing
to BiV pacing was tested. The following null hypothesis was considered:
H0 : Dmultispot DBiV ¼ 0%
versus the alternative hypothesis
H1 : Dmultispot DBiV 6¼ 0%:
This analysis was pre-specified in the statistical analysis plan of the iSPOT study, and is in
line with standard statistical analysis for non-inferiority trials.
No correction for multiple testing was performed. To determine the correlations between
absolute LV+dP/dtmax value and Q-LV or QRS duration as well as the correlations between %
change LV+dP/dtmax value and Q-LV ratio or QRS ratio, linear multiple regression analysis
was used. Data are expressed as mean±SD (unless indicated otherwise).
Results
Baseline Characteristics and Hemodynamic Results
Full protocol was obtained in 24 subjects (77%) from the 31 patients enrolled in the iSPOT
study. One subject was excluded from the cohort for not fulfilling all the inclusion criteria.
Left Ventricular MultiSPOT Pacing for CRT (iSPOT)
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Fig 1 shows a flowchart of the enrolled patients and the characteristics of 30 patients are shown
in Table 3. The excluded patients had hemodynamic instability (n = 2), electrical instability
(n = 1), sensing problems (n = 2) and absence of stable position in tested veins (n = 1). Ische-
mic aetiology was observed in 58% of patients. Tested LV lead locations were: a) posterolateral
in 12 patients (50%), b) lateral in 11 (46%) and c) anterolateral in one patient (4%). Bipolar RV
stimulation was performed from either RV-apex in 16 pts (63%) or RV-septum in 8 pts (37%).
Anatomic evaluation indicated the LV distal tip was placed on average 58% from the base indi-
cating that the distal electrode was placed more in the mid instead of the true apical region.
Baseline LV+dP/dtmax measured with AAI pacing mode was 677±215 mmHg/sec and
increased (taking into account all AV-delays tested) in the LV-distal, LV-mid, LV-prox, and
multiSPOT configuration to 818±217, 822±248, 819±226 and 845±235 mmHg/sec
respectively.
Hemodynamic Response after AV delay optimisation. AV delay curves for all configura-
tions and subsequent determination of AV delays with the maximal LV+dP/dtmax for 1
patient is depicted on Fig 2. Following AV delay optimisation, LV+dP/dtmax increased respec-
tively by 28.9±3.2% (LV-dist) (mean±standard error), 28.3±2.7% (LV-mid), 29.5±3.0% (LV-
prox) and 31.0±3.3% (MultiSPOT) as compared to baseline. Individual response measured by
LV+dP/dtmax is shown on Fig 3. No difference in LV+dP/dtmax was noted between the differ-
ent configurations for the best AV interval (max difference of 2.8±1.5% between MultiSPOT
Fig 1. Flowchart of the enrolled patients.
doi:10.1371/journal.pone.0154024.g001
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and BiV mid, all p-values>0.05). The difference between the optimal AV-delay calculated by
the CardioSyncTM Algorithm (depicted as AV = 0 on Fig 2) and the real optimal AV-delay,
which lead to maximal hemodynamic response as determined by regression analysis, ranged
from -1.7ms (LV-prox) to +5.8ms (LV-mid). The optimal AV-interval, calculated by the
Table 3. Characteristics of studied population. QRSmorphology was classified according to AHA/ACCF/
HRS guidelines. Patient aetiology other means inflammation induced cardiomyopathy.
Patient Characteristics Total Subjects (N = 30)
Gender (N,%)
Male 24 (80.0%)
Female 6 (20.0%)
Age (years) 61.0 ± 13.0
Heart Rate (bpm) 74.4 ± 14.7
Systolic Blood Pressure (mmHg) 126.4 ± 19.5
Diastolic Blood Pressure (mmHg) 77.0 ± 11.6
LV Ejection Fraction (%) 24.3 ± 6.1
New York Heart Association (N,%)
Class II 11 (36.7%)
Class III 19 (63.3%)
Cardiomyopathy
Dilated/congestive 14 (46.7%)
Ischemic 17 (56.7%)
Other 1 (3.3%)
QRS duration (ms) 170.9 ± 20.0
LBBB (N,%) 30 (100%)
doi:10.1371/journal.pone.0154024.t003
Fig 2. Regression curve constructed through percentage LV+dP/dtmax changes during each
configuration depending on AV delay in one patient. Red dot indicates calculated maximal average
response at AV-best. AV = 0 indicates AV-delay calculated by CardioSyncTM formula. AV-delay delta stands
for change from AV-delay calculated by CardioSyncTM formula in ms.
doi:10.1371/journal.pone.0154024.g002
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CardioSync™ was 164±31ms, ranging from 110 to 240ms. The PQ-time during baseline AAI-
pacing was 257±55ms, ranging from 180 to 387ms.
Hemodynamic Response and Aetiology. MultiSPOT pacing revealed a significantly
higher % increase in LV+dP/dtmax response than BiV dist pacing in ischemic patients (mean
difference ± standard error: 5.7 ± 2.2, superiority testing: p = 0.0224) but MultiSPOT was not
significantly different to BiV distal pacing in non-ischemic patients (mean
difference ± standard error: -2.4±1.7, inferiority testing: p = 0.1883). No significant differences
in LV+dP/dt were noted when comparing MSP versus BiV mid or MSP versus BIV prox in
both ischemic and non-ischemic patients (p> 0.083).
Individual Response. Patients were categorized according to their max response in LV
+dP/dtmax (Fig 3). It was noted that MSP performed better (defined as an increase in LV +dP/
dt max of 10% over best BiV) in 2 patients (Fig 4; patients 2 and 24). MSP was not effective
in increasing LV+dP/dtmax values in acute non- or low responders (<10% increase in LV+dP/
Fig 3. Boxplot of LV+dP/dtmax% increase for the different configurations.Distal, mid and prox denote LV-electrode position on the
LV-lead. MultiSPOT denote pacing on all three LV-electrode positions simultaneously. Solid line depicts mean value and boxes are 75
and 25 percentiles. Whiskers represent 2.5 and 97.5% percentiles.
doi:10.1371/journal.pone.0154024.g003
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dtmax values). In two of 24 patients one conventional BiV setting resulted in>10% better
hemodynamic response compared to MSP suggesting a possible detrimental effect of MSP in
these patients.
Impact of configuration upon QRS-width changes
Conventional BiV pacing decreased the QRS-width from 167±19ms to 149±19ms, 145±19ms,
147±19ms during LV-distal, LV-mid and LV-prox pacing, respectively. There was a small
additional decrease in QRS width during MSP pacing to 143±17ms, which was significant in
comparison to BiV-dist (p = 0.004) but to none of the other configurations (BiV-mid;
p = 0.121 or BiV-prox; p = 0.056). No strong correlations between absolute LV+dP/dtmax and
QRS-width (R = -0.310) or % change LV+dP/dtmax and QRS-width ratio (i.e. QRS-pacing set-
ting/QRS-baseline) were noted (R = -0.136). Figs 5 and 6 summarize QRS and the normalized
Q-LV-values for the different pacing configurations. The normalized QLV timings were similar
for all the three electrodes on the LV-lead, occurring at 0.782±0.077, 0.795±0.038 and 0.797
±0.038 QRS duration for distal, mid and prox electrode positions, respectively. This indicates
that LV activation occurs late, that is at 80% of the QRS-time. The average inter-electrode time
delay between earliest and latest activation was 13±8 ms, varying from 1 to 21 ms. No correla-
tion was observed between Q-LV-timing and LV+dP/dtmax (R = 0.053) and between max
%-change LV+dP/dtmax and Q-LV-ratio (i.e. Q-LV/QRS-width) (R = 0.007).
Discussion
The present study was designed to investigate the feasibility of increased efficacy of multipoint
pacing in CRT-eligible patients, using invasive measurements only in experienced hospitals to
Fig 4. Individual contractility data per patient. Presented are the maximal % LV+dP/dtmax values (mean and confidence intervals)
for all 24 patients for all different BiV and MultiSPOT configurations. Patient 6 has no LV-distal data because of intolerable phrenic nerve
stimulation at this position. For more explanation see text.
doi:10.1371/journal.pone.0154024.g004
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execute safely this type of research (see: section limitations). The study also included less inva-
sive measurements (eg electrical parameters like Q-LV and QRS-width) which are linked to the
acute possible beneficial effect of multipoint pacing. The study demonstrated that after AV
delay optimization MSP had no additional acute improvement in systolic LV pump function
compared to conventional biventricular pacing in LBBB patients with heart failure. In this
patient cohort the optimal hemodynamic response could be achieved by tailored AV-delay
optimization using the CardioSyncTM algorithm.
Fig 5. QRSwidth values at different pacingmodes.QRS-width reduction by BiV pacing approximates
15% and is only slightly more reduced by MultiSPOT pacing. It has weak correlation with % LV+dP/dtmax
increase (R = -0.136). (B)
doi:10.1371/journal.pone.0154024.g005
Fig 6. QLV/QRS values upon different pacingmodes.Normalized QLV/QRS values for the different
electrodes on the Multi-electrode LV lead.Data and correlations are presented as mean±SD. * indicates
significant different fromMultiSPOT.
doi:10.1371/journal.pone.0154024.g006
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Hemodynamic effects of conventional biventricular pacing
The differences in hemodynamic benefit of BiV pacing compared to AAI) using the different
electrodes on the multipolar lead were small (distal 28.94%, mid 28.26%, and proximal elec-
trode 29.45%) but the absolute value relatively high when compared to other studies. The high
acute response to CRT in the current study is likely explained by the optimal positioning of the
LV lead in the lateral vein [3, 18, 19] and the specific pacing protocol in which we measured
the hemodynamic response by repetitive measurements of 10–20 seconds which differs from
the more steady state measurements over a minute pacing interval generally used. In addition,
only patients with LBBB (known high responders) were included. Moreover, a relatively high
pacing rate was used together with individual optimization of AV delays, maximizing the
CRT-effect.
Hemodynamic effects of MultiSPOT pacing and comparison with
previous studies
The findings of the current study do not support the hypothesis that simultaneous pacing
using all three electrodes (MultiSPOT; MSP) increased the acute hemodynamic CRT response
through activation of a greater amount of LV tissue in patients with LBBB beyond conventional
CRT. For comparison of our results to published data, we can classify prior studies of multisite
pacing into those using simultaneous stimulation with a VV-delay of 0 ms (simultaneous
MSP) and those using varying delays between the LV electrodes (sequential MSP). In the
simultaneous MSP studies, the acute hemodynamic benefit of MSP was either small and non-
significant[10, 20] or small but statistically different[12, 15] compared to conventional BiV-
pacing. The difference may be explained by the AV-delay as in the studies which showed posi-
tive hemodynamic effect of MSP[12, 15] the AV-delay was similar for all patients[15] while in
the studies which did not show significant benefit an individualized patient-optimal AV-delay
was used.[10, 21] This is in-line with the current findings, where AV-optimization would sug-
gest that MSP has no incremental benefit and, a previous study using two LV-leads.[21]
Although there is a lot of debate what the exact AV-delay for the individual patient should be,
it is well recognized that not every patient benefits from a standardly chosen AV-delay.[17] In
some “sequential MSP-studies” to ensure full LV capture the AV-delay was kept very short
(25–50 ms)[13, 22] whereas others used a more physiological AV-delay.[9, 14] In these studies
MSP demonstrated a small and variable acute hemodynamic benefit.[23] In addition, one pre-
vious study has shown that MSP improves longer-term CRT response.[24] Interpretation of
the results of these studies might be hampered by the methodologies used in these papers
which are not always comprehensive and AV-optimization was not performed. The rationale
for using sequential LV-pacing is unclear. The electrical distance between the electrodes of cur-
rent quadripolar leads measured in the normal CRT population during sinus rhythm ranges
between 10 and 20ms (current study and[10]). This may limit possible intervention with an
electrical therapy like CRT. Ideal inter-electrode spacing (maximal anatomic distance on quad-
ripolar lead) to achieve maximal MSP response needs to be investigated.[25]
Individual patient response to MultiSPOT pacing
In our study it was noted that MSP performed better (defined as an increase in LV+dP/dt max
of more than 10% over best BiV) in 2 patients. Previous studies have indicated that MSP could
be more beneficial in ischemic patients[11, 26] and both our ‘MSP responders’ had an ischemic
aetiology. Studies have suggested that a non-responder could be turned into a responder with
MSP[27] however, if we define non-responders in our study as patients with10% increase in
Left Ventricular MultiSPOT Pacing for CRT (iSPOT)
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LV+dP/dtmax in any BiV configuration, MSP could not turn these patients into a responder
(i.e.>10% increase in LV+dP/dtmax). It should also be noted in the current study that MSP
could have detrimental effects on hemodynamic function when compared to the best BiV pac-
ing configuration with 2 out of 24 (8.3%) patients with one BiV setting more than 10% better
than MSP which has also been shown previously.[12] The nature of this phenomenon is
unclear but the creation of functional block, interference with the sequence of activation or
mitral valve function might be implicated. Such findings should raise caution in the use of
MSP in CRT[10] and more mechanistic studies are warranted to investigate the role of MSP in
individual patients. In line with this Sohal et al[20] recently showed that a significant hemody-
namic benefit of MSP was observed only in hemodynamic non-responders to conventional
BiV pacing and that the positive effect of MSP was only seen in patients that did not fulfill strict
criteria for LBBB and that tended to have an ischemic aetiology. In keeping with the findings of
Sohal et al a comparison of ischemic patients versus non-ischemic patients in the current study
revealed that in ischemic patients, MSP increased LV+dP/dtmax when compared to LV-distal
pacing but not to LV-mid or LV-prox pacing. These findings indicate that in this LBBB-specific
population lead location within the coronary vein is important.
MultiSPOT pacing and its effects on electrical parameters
Intuitively a more simultaneous activation of the LV with MSP would be expected to enhance
resynchronization and thereby result in hemodynamic benefit. Data on QRS-narrowing as an
indicator for CRT-response are controversial.[2, 28, 29] lt was found that compared to conven-
tional BiV-pacing MSP elicited a significantly greater (absolute difference = 4ms) QRS-width
narrowing.[15] In the current study MSP resulted in a significant QRS-narrowing only when
compared to conventional BiV pacing from the distal electrode.[15] Importantly the correla-
tion between QRS-width and contractility increase was weak in our study, indicating that QRS-
change with pacing may not be a reliable predictor of acute hemodynamic response. Other
modalities such as vectorcardiography might be a more promising electrophysiological predic-
tor of CRT response[30], perhaps in conjunction with known predictors such as baseline con-
tractility (LV+dP/dtmax) value, QRS duration or morphology.[18] In keeping with our
findings LV activation times measured by invasive mapping in a canine model showed that
MSP with up to seven stimulation sites is capable of decreasing total LV-activation time but the
improvement in contractility was non-significant when compared to the optimal single BiV
stimulation.[3] Retrospective analyses show that patients with LV leads implanted at sites with
a long Q-LV are more likely to respond to CRT[31] and Zanon et al[15] found a good correla-
tion between Q-LV and hemodynamic response with MSP. Our study did not confirm this
finding but this is likely due to the comparable Q-LV-timings because of using the lateral vein
in all patients.
Limitations
The present study used the change in invasively measured left ventricular +dP/dtmax as
parameter to define acute CRT response, while other hemodynamic parameters can be used
such as stroke work using pressure-volume loops or blood pressure for acute CRT-feedback
[32]. An acute increase in one of these parameters identifies patients who are most likely to
respond to CRT. But it is important to realize that these observations do not provide an insight
into which invasive parameter is superior for identifying long-term response to CRT and how
they relate to the traditional identifiers of response. This study does not provide an answer to
this question either, but with the specific repetitive methodology used the likelihood of acute
parameters being predictive should increase considerably. [33] In this study only patients with
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broad LBBB morphology were deliberately included. Therefore, the results may not be valid for
other patients groups such as ischemic patients or patients without strict LBBB where CRT
response is reduced. The number of patients (although from multiple centers) was small but
comparable with previous (single-center) studies. The intention was to focus on AV-delay.
Due to time constraint we only tested MSP in one vein and did not optimize VV-delay. Proto-
col of the study was limited by ethical considerations not to exceed “skin-to-skin” procedure
time, compared to an accepted average time of the procedure in less experienced centers. The
data from the present study need to be confirmed in larger prospective studies delineating dif-
ferent CRT-populations. One must be aware that management of heart failure requires a multi-
modal approach. Besides the optimization of device settings, also lifestyle modifications and
sustained optimized medication play very important roles.
Conclusions
In this heart failure population with wide left bundle branch block and indication for cardiac
resynchronization therapy, tested in a noise-minimizing high-replicate protocol with opti-
mized atrio-ventricular delay, MultiSPOT left ventricular pacing demonstrated no significant
acute improvement in contractility over the one best biventricular pacing site. Future studies to
assess the long term effect and possible multisite pacing benefits in patients with ischemic aeti-
ology and other forms of intraventricular conduction disorders are warranted. Optimization of
atrioventricular delay affected the best performance of all pacing configurations.
Supporting Information
S1 Protocol. Left Ventricular MultiSpot Pacing for CRT (iSpot) Clinical Investigational
Plan.
(PDF)
S1 TREND Checklist.
(PDF)
Acknowledgments
We would like to acknowledge the help of Bärbel Maus (Medtronic, Inc.) for statistical evalua-
tion. This study was sponsored by Bakken Research Center, Medtronic Maastricht, The
Netherlands.
Author Contributions
Conceived and designed the experiments: RC BS JH DF. Performed the experiments: MS AS
RL FvH CRMvH VK DF. Analyzed the data: RC JH. Contributed reagents/materials/analysis
tools: RC BS JH. Wrote the paper: MS AS RL FvH CRMvH VK DF JH BS RC.
References
1. Auricchio A, Prinzen FW. Non-responders to cardiac resynchronization therapy: the magnitude of the
problem and the issues. Circulation journal: official journal of the Japanese Circulation Society. 2011;
75(3):521–7. Epub 2011/02/18. JST.JSTAGE/circj/CJ-10-1268 [pii]. PMID: 21325727.
2. AbrahamWT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in
chronic heart failure. The New England journal of medicine. 2002; 346(24):1845–53. Epub 2002/06/14.
doi: 10.1056/NEJMoa013168 PMID: 12063368.
3. Ploux S, Strik M, van Hunnik A, van Middendorp L, Kuiper M, Prinzen FW. Acute electrical and hemody-
namic effects of multisite left ventricular pacing for cardiac resynchronization therapy in the
Left Ventricular MultiSPOT Pacing for CRT (iSPOT)
PLOS ONE | DOI:10.1371/journal.pone.0154024 April 28, 2016 13 / 16
dyssynchronous canine heart. Heart rhythm: the official journal of the Heart Rhythm Society. 2014; 11
(1):119–25. Epub 2013/10/15. doi: 10.1016/j.hrthm.2013.10.018 PMID: 24120876.
4. Merchant FM, Heist EK, McCarty D, Kumar P, Das S, Blendea D, et al. Impact of segmental left ventri-
cle lead position on cardiac resynchronization therapy outcomes. Heart rhythm: the official journal of
the Heart Rhythm Society. 2010; 7(5):639–44. Epub 2010/03/20. doi: 10.1016/j.hrthm.2010.01.035
PMID: 20298819.
5. Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF, et al. Impact of coronary sinus
lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term fol-
low-up. Journal of cardiovascular electrophysiology. 2004; 15(10):1120–5. doi: 10.1046/j.1540-8167.
2004.04089.x PMID: 15485432.
6. Bordachar P, Alonso C, Anselme F, Boveda S, Defaye P, Garrigue S, et al. Addition of a second LV
pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trial. Journal
of cardiac failure. 2010; 16(9):709–13. Epub 2010/08/28. doi: 10.1016/j.cardfail.2010.04.010 PMID:
20797593.
7. Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, et al. A randomized comparison of triple-
site versus dual-site ventricular stimulation in patients with congestive heart failure. Journal of the
American College of Cardiology. 2008; 51(15):1455–62. Epub 2008/04/12. doi: 10.1016/j.jacc.2007.11.
074 PMID: 18402900.
8. Rinaldi CA, Burri H, Thibault B, Curnis A, Rao A, Gras D, et al. A review of multisite pacing to achieve
cardiac resynchronization therapy. Europace: European pacing, arrhythmias, and cardiac electrophysi-
ology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiol-
ogy of the European Society of Cardiology. 2015; 17(1):7–17. doi: 10.1093/europace/euu197 PMID:
25214507.
9. Shetty AK, Sohal M, Chen Z, Ginks MR, Bostock J, Amraoui S, et al. A comparison of left ventricular
endocardial, multisite, and multipolar epicardial cardiac resynchronization: an acute haemodynamic
and electroanatomical study. Europace: European pacing, arrhythmias, and cardiac electrophysiology:
journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of
the European Society of Cardiology. 2014; 16(6):873–9. Epub 2014/02/15. doi: 10.1093/europace/
eut420 PMID: 24525553.
10. van Gelder BM, Bracke FA. Acute hemodynamic effects of single- and dual-site left ventricular pacing
employing a dual cathodal coronary sinus lead. Pacing and clinical electrophysiology: PACE. 2015; 38
(5):558–64. doi: 10.1111/pace.12606 PMID: 25640457.
11. Ginks MR, Duckett SG, Kapetanakis S, Bostock J, Hamid S, Shetty A, et al. Multi-site left ventricular
pacing as a potential treatment for patients with postero-lateral scar: insights from cardiac magnetic res-
onance imaging and invasive haemodynamic assessment. Europace: European pacing, arrhythmias,
and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and car-
diac cellular electrophysiology of the European Society of Cardiology. 2012; 14(3):373–9. Epub 2011/
11/03. doi: 10.1093/europace/eur336 PMID: 22045930.
12. Thibault B, Dubuc M, Khairy P, Guerra PG, Macle L, Rivard L, et al. Acute haemodynamic comparison
of multisite and biventricular pacing with a quadripolar left ventricular lead. Europace: European pacing,
arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhyth-
mias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2013; 15(7):984–
91. Epub 2013/03/01. doi: 10.1093/europace/eus435 PMID: 23447571.
13. Rinaldi CA, Leclercq C, Kranig W, Kacet S, Betts T, Bordachar P, et al. Improvement in acute contractil-
ity and hemodynamics with multipoint pacing via a left ventricular quadripolar pacing lead. Journal of
interventional cardiac electrophysiology: an international journal of arrhythmias and pacing. 2014; 40
(1):75–80. Epub 2014/03/15. doi: 10.1007/s10840-014-9891-1 PMID: 24626999.
14. Pappone C, Calovic Z, Vicedomini G, Cuko A, McSpadden LC, Ryu K, et al. Multipoint left ventricular
pacing improves acute hemodynamic response assessed with pressure-volume loops in cardiac resyn-
chronization therapy patients. Heart rhythm: the official journal of the Heart Rhythm Society. 2014; 11
(3):394–401. Epub 2013/12/03. doi: 10.1016/j.hrthm.2013.11.023 PMID: 24291411.
15. Zanon F, Baracca E, Pastore G, Marcantoni L, Fraccaro C, Lanza D, et al. Multipoint pacing by a left
ventricular quadripolar lead improves the acute hemodynamic response to CRT compared with con-
ventional biventricular pacing at any site. Heart rhythm: the official journal of the Heart Rhythm Society.
2015; 12(5):975–81. doi: 10.1016/j.hrthm.2015.01.034 PMID: 25625721.
16. Whinnett ZI, Davies JE, Willson K, Manisty CH, Chow AW, Foale RA, et al. Haemodynamic effects of
changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a con-
sistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interven-
tricular delay. Heart. 2006; 92(11):1628–34. Epub 2006/05/20. doi: 10.1136/hrt.2005.080721 PMID:
16709698; PubMed Central PMCID: PMCPMC1861257.
Left Ventricular MultiSPOT Pacing for CRT (iSPOT)
PLOS ONE | DOI:10.1371/journal.pone.0154024 April 28, 2016 14 / 16
17. Martin DO, Lemke B, Birnie D, Krum H, Lee KL, Aonuma K, et al. Investigation of a novel algorithm for
synchronized left-ventricular pacing and ambulatory optimization of cardiac resynchronization therapy:
results of the adaptive CRT trial. Heart rhythm: the official journal of the Heart Rhythm Society. 2012; 9
(11):1807–14. Epub 2012/07/17. doi: 10.1016/j.hrthm.2012.07.009 PMID: 22796472.
18. Bogaard MD, Houthuizen P, Bracke FA, Doevendans PA, Prinzen FW, Meine M, et al. Baseline left
ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in
patients with cardiac resynchronization therapy. European journal of heart failure. 2011; 13(10):1126–
32. Epub 2011/07/28. doi: 10.1093/eurjhf/hfr094 PMID: 21791536.
19. Shetty AK, Duckett SG, Ma YL, Kapetanakis S, Ginks M, Bostock J, et al. The acute hemodynamic
response to LV pacing within individual branches of the coronary sinus using a quadripolar lead. Pacing
and clinical electrophysiology: PACE. 2012; 35(2):196–203. Epub 2011/12/01. doi: 10.1111/j.1540-
8159.2011.03268.x PMID: 22126664.
20. Sohal M, Shetty A, Niederer S, Lee A, Chen Z, Jackson T, et al. Mechanistic insights into the benefits of
multisite pacing in cardiac resynchronization therapy: The importance of electrical substrate and rate of
left ventricular activation. Heart rhythm: the official journal of the Heart Rhythm Society. 2015; 12
(12):2449–57. doi: 10.1016/j.hrthm.2015.07.012 PMID: 26165943.
21. Padeletti L, Colella A, Michelucci A, Pieragnoli P, Ricciardi G, Porciani MC, et al. Dual-site left ventricu-
lar cardiac resynchronization therapy. The American journal of cardiology. 2008; 102(12):1687–92.
Epub 2008/12/10. doi: 10.1016/j.amjcard.2008.08.016 PMID: 19064025.
22. Rinaldi CA, Kranig W, Leclercq C, Kacet S, Betts T, Bordachar P, et al. Acute effects of multisite left
ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization ther-
apy. Journal of cardiac failure. 2013; 19(11):731–8. Epub 2013/11/23. doi: 10.1016/j.cardfail.2013.10.
003 PMID: 24263116.
23. Shetty AK, Mehta P, Bostock J, Rinaldi CA. Quad-site pacing using a quadripolar left ventricular pacing
lead. Pacing and clinical electrophysiology: PACE. 2013; 36(2):e48–50. Epub 2011/12/01. doi: 10.
1111/j.1540-8159.2011.03267.x PMID: 22126629.
24. Pappone C, Calovic Z, Vicedomini G, Cuko A, McSpadden LC, Ryu K, et al. Improving cardiac resyn-
chronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study.
Heart rhythm: the official journal of the Heart Rhythm Society. 2015; 12(6):1250–8. doi: 10.1016/j.
hrthm.2015.02.008 PMID: 25678057.
25. Gottlieb C, Klugerz B. Multipoint pacing: can we connect the dots to improve resynchronization ther-
apy? Heart rhythm: the official journal of the Heart Rhythm Society. 2014; 11(3):402–3. doi: 10.1016/j.
hrthm.2013.12.015 PMID: 24333284.
26. Niederer SA, Shetty AK, Plank G, Bostock J, Razavi R, Smith NP, et al. Biophysical modeling to simu-
late the response to multisite left ventricular stimulation using a quadripolar pacing lead. Pacing and
clinical electrophysiology: PACE. 2012; 35(2):204–14. Epub 2011/11/02. doi: 10.1111/j.1540-8159.
2011.03243.x PMID: 22040178.
27. Ginks MR, Shetty AK, Lambiase PD, Duckett SG, Bostock J, Peacock JL, et al. Benefits of endocardial
and multisite pacing are dependent on the type of left ventricular electric activation pattern and pres-
ence of ischemic heart disease: insights from electroanatomic mapping. Circulation Arrhythmia and
electrophysiology. 2012; 5(5):889–97. Epub 2012/07/27. doi: 10.1161/CIRCEP.111.967505 PMID:
22832673.
28. Molhoek SG, VANE L, BootsmaM, Steendijk P, Van Der Wall EE, Schalij MJ. QRS duration and short-
ening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart
failure. Pacing and clinical electrophysiology: PACE. 2004; 27(3):308–13. PMID: 15009855
29. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular
pacing in patients with heart failure and intraventricular conduction delay. The New England journal of
medicine. 2001; 344(12):873–80. doi: 10.1056/NEJM200103223441202 PMID: 11259720.
30. van Deursen CJ, Wecke L, van EverdingenWM, Stahlberg M, JanssenMH, Braunschweig F, et al.
Vectorcardiography for optimization of stimulation intervals in cardiac resynchronization therapy. Jour-
nal of cardiovascular translational research. 2015; 8(2):128–37. doi: 10.1007/s12265-015-9615-7
PMID: 25743446; PubMed Central PMCID: PMCPMC4382533.
31. Gold MR, Yu Y, Singh JP, Stein KM, Birgersdotter-Green U, Meyer TE, et al. The effect of left ventricu-
lar electrical delay on AV optimization for cardiac resynchronization therapy. Heart rhythm: the official
journal of the Heart Rhythm Society. 2013; 10(7):988–93. doi: 10.1016/j.hrthm.2013.03.009 PMID:
23499621.
32. Whinnett ZI, Francis DP, Denis A, Willson K, Pascale P, van Geldorp I, et al. Comparison of different
invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization
therapy: implications for clinical trial design and clinical practice. International journal of cardiology.
2013; 168(3):2228–37. Epub 2013/03/14. doi: 10.1016/j.ijcard.2013.01.216 PMID: 23481908; PubMed
Central PMCID: PMCPMC3819984.
Left Ventricular MultiSPOT Pacing for CRT (iSPOT)
PLOS ONE | DOI:10.1371/journal.pone.0154024 April 28, 2016 15 / 16
33. Pabari PA, Willson K, Stegemann B, van Geldorp IE, Kyriacou A, Moraldo M, et al. When is an optimiza-
tion not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio)
in optimization of cardiac resynchronization therapy, and how to measure and maximize it. Heart failure
reviews. 2011; 16(3):277–90. Epub 2010/11/27. doi: 10.1007/s10741-010-9203-5 PMID: 21110226;
PubMed Central PMCID: PMCPMC3074062.
Left Ventricular MultiSPOT Pacing for CRT (iSPOT)
PLOS ONE | DOI:10.1371/journal.pone.0154024 April 28, 2016 16 / 16
